+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06834113

Comparing Pain from Cabotegravir and Rilpivirine Injections in Adults with HIV-1 Testing Injection Site and Virtual Reality Headset Use

Led by Centre Hospitalier Régional d'Orléans · Updated on 2025-12-30

120

Participants Needed

5

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how the pain caused by injectable antiretroviral ARV treatments Cabotegravir and Rilpivirine affects patients with HIV-1. This study compares pain intensity based on the injection siteeither dorsogluteal or ventroglutealand whether patients wear a virtual reality headset during the injection. The goal is to understand how these factors influence pain and tolerance in HIV-1 patients who are either new to or already receiving these injections. Participants will receive four injections in different sequences dorsogluteal injection without a headset, ventrogluteal injection without a headset, dorsogluteal injection with a virtual reality headset, and ventrogluteal injection with a headset. Each participant experiences all four procedures in a randomized order. The study includes standard care visits for injections, pain assessment, and monitoring over several months. Throughout the study, patients will attend five visits including an inclusion visit, multiple follow-ups, and an end-of-study visit. Nurses will examine injection sites and collect information on any pain and side effects. Patients will rate their pain on a numerical scale immediately after injection, several hours later, and daily for seven days. They will also keep a log to track pain and complete satisfaction questionnaires. Researchers will monitor pain intensity, treatment tolerance, and patient preferences over approximately seven to eight months.

CONDITIONS

Brief Title

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Research Team

D

Daniela PIRES ROTEIA

F

Fanny LOUAT

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here